Cargando…

Mavrilimumab for severe COVID-19

Detalles Bibliográficos
Autores principales:	Khan, Adil Rashid, Soneja, Manish, Tirlangi, Praveen Kumar, Wig, Naveet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833724/ https://www.ncbi.nlm.nih.gov/pubmed/33521661 http://dx.doi.org/10.1016/S2665-9913(20)30306-4

Ejemplares similares

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2020)

False reassurance or inadequate drug levels?
por: Tirlangi, Praveen, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

436. SARS-CoV-2 Seropositivity and Association with Dengue Severity in Adults
por: Priyadarshi, Megha, et al.
Publicado: (2023)

Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
por: Tilangi, Praveen, et al.
Publicado: (2020)

Hydroxychloroquine pre-exposure prophylaxis for COVID-19 among healthcare workers: Initial experience from India
por: Kadnur, Harshith B., et al.
Publicado: (2022)

COVID-19 and TB co-infection - 'Finishing touch'' in perfect recipe to 'severity’ or ‘death'
por: Kumar, Dr. Rohit, et al.
Publicado: (2020)

Battling COVID-19: using old weapons for a new enemy
por: Kumar, Rohit, et al.
Publicado: (2020)

Clinical and Laboratory Features Associated with Acute Kidney Injury in Severe Malaria
por: Anghan, Hiren, et al.
Publicado: (2018)

Pathophysiology of COVID-19-associated acute respiratory distress syndrome
por: Narayan, Ananthu, et al.
Publicado: (2021)

Prevalence of Long COVID-19 and its Impact on Quality of Life Among Outpatients With Mild COVID-19 Disease at Tertiary Care Center in North India
por: Sarda, Radhika, et al.
Publicado: (2022)

Role of Voriconazole in the Management of Invasive Central Nervous System Aspergillosis: A Case Series from a Tertiary Care Centre in India
por: Gupta, Nitin, et al.
Publicado: (2020)

Ambispective study of clinical picture, management practices and outcome of snake bite patients at tertiary care centre in Northern India
por: Jadon, Ranveer Singh, et al.
Publicado: (2021)

Is there antibody-dependent enhancement in SARS Coronavirus 2?
por: Kumar, Rohit, et al.
Publicado: (2020)

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2013)

Risk Factors of Severity and Mortality Among COVID-19 Patients: A Prospective Observational Study From a Tertiary Care Center
por: Arunan, Bharathi, et al.
Publicado: (2022)

Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
por: Crotti, Chiara, et al.
Publicado: (2017)

Mortality in systemic lupus erythematosus at a teaching hospital in India: A 5-year retrospective study
por: Bharath, Gangadharaiah, et al.
Publicado: (2019)

2156. To Evaluate the Role of Kit-Based Loop-Mediated Isothermal Amplification (TB-LAMP) Assay in the Diagnosis of Tubercular Lymphadenitis
por: Nischal, Neeraj, et al.
Publicado: (2019)

Lyme arthritis: A prospective study from India
por: Gupta, Nitin, et al.
Publicado: (2019)

Positive Expiratory Pressure Oxygen Therapy for Respiratory Distress: A Single-arm Feasibility Trial
por: Dhochak, Nitin, et al.
Publicado: (2022)

Effect of Implementation of ADA/AACE Guidelines on the Management of Hospitalized Hyperglycemic Patients Through Training of Residents: A Tertiary Care Center Study
por: Amrith, B. P, et al.
Publicado: (2018)

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
por: De Luca, Giacomo, et al.
Publicado: (2020)

Baroreflex sensitivity is impaired in survivors of mild COVID‐19 at 3–6 months of clinical recovery; association with carotid artery stiffness
por: Srivastava, Prachi, et al.
Publicado: (2023)

Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use
por: Bhatnagar, Tarun, et al.
Publicado: (2020)

Association of Dengue Virus and Leptospira Co-Infections with Malaria Severity
por: Mandage, Rajendra, et al.
Publicado: (2020)

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis
por: Di Franco, Manuela, et al.
Publicado: (2014)

A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
por: Weinblatt, Michael E., et al.
Publicado: (2017)

Model‐Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab
por: Wang, Bing, et al.
Publicado: (2017)

868. Early Organism Identification by Matrix Assisted Laser Desorption Ionization Time Of Flight Mass Spectrometry (MALDI TOF MS) Decreases the Time to Optimal Antibiotic Therapy for Common Bacterial Infections
por: Keri, Vishakh C, et al.
Publicado: (2023)

Retrospective analysis of IgG4-related disease cases at a tertiary care centre in India
por: Bhatt, Manasvini, et al.
Publicado: (2022)

2654. Myocarditis in Dengue: A Prospective Observational Study
por: Soneja, Manish, et al.
Publicado: (2019)

375. Cryptococcal Antigenemia in Advanced HIV Infection
por: Ahuja, Jatin, et al.
Publicado: (2019)

Gargle lavage as a viable alternative to swab for detection of SARS-CoV-2
por: Mittal, Ankit, et al.
Publicado: (2020)

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial
por: Cremer, Paul C, et al.
Publicado: (2021)

ACE2 protein expression in lung tissues of severe COVID-19 infection
por: Gheware, Atish, et al.
Publicado: (2022)

Diagnostic Evaluation of Non-Interpretable Results Associated with rpoB Gene in Genotype MTBDRplus Ver 2.0
por: Singh, Binit Kumar, et al.
Publicado: (2020)

Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience
por: Aggarwal, Anivita, et al.
Publicado: (2022)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04st9cjhr4b46t0bkh07hc9c0q